Premaitha Health, an international molecular diagnostics group focused on prenatal testing, has acquired Taiwanese Yourgene Bioscience.
As a part of the acquisition agreement, Dr Bill Chang and Mr Alan Chang will be appointed as Directors of the Company.
It is expected that the acquisition will bring increased access to Asia, the world’s fastest growing NIPT market, as well as opportunities for cross-selling. Yourgene has already won new Indonesian partner who will offer the first in-country NIPT service based on the Yourgene solution, and a laboratory in India which has purchased next-generation sequencing equipment ready to launch a Yourgene-based NIPT service in Q2.